CVE-2024-26492

CVE-2024-26492 is a medium-severity vulnerability in Oretnom23 Online Diagnostic Lab Management System with a CVSS 3.x base score of 6.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Description

An issue in Online Diagnostic Lab Management System 1.0 allows a remote attacker to gain control of a 'Staff' user account via a crafted POST request using the id, email, password, and cpass parameters.

Frequently asked questions

What is CVE-2024-26492?
An issue in Online Diagnostic Lab Management System 1.0 allows a remote attacker to gain control of a 'Staff' user account via a crafted POST request using the id, email, password, and cpass parameters.
How severe is CVE-2024-26492?
CVE-2024-26492 has a CVSS 3.x base score of 6.3, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability low.
Is CVE-2024-26492 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (44th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2024-26492?
CVE-2024-26492 affects Oretnom23 Online Diagnostic Lab Management System. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2024-26492?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2024-26492 have an EU (EUVD) identifier?
Yes. CVE-2024-26492 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-23757.
When was CVE-2024-26492 published?
CVE-2024-26492 was published on 2024-03-07 and last updated on 2026-06-17.

References

Affected products (1)